[The treatment of chronic myeloid leukemia in chronic phase with interferons].
Guilhot
F
F
Département d'Hématologie et Oncologie Médicale, Hôpital Jean-Bernard, Poitiers, France.
D005500:Follow-Up Studies; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D011994:Recombinant Proteins; D012074:Remission Induction; D012307:Risk Factors
D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins
Le traitement de la leucémie myéloïde chronique en phase chronique par les interférons.